05. Atopic eczema/dermatitis

Efficacy and Safety of Baricitinib in Moderate to Severe Atopic Dermatitis: Results of Two Phase 3 Monotherapy Randomized, Double-Blind, Placebo-Controlled 16-week Trials (BREEZE-AD1 and BREEZE-AD2)

Eric L. Simpson, Jean-philippe Lacour, Lynda Spelman, Ricardo Galimberti, Lawrence Eichenfield, Robert Bissonnette, Brett A. King, Jacob P. Thyssen, Jonathan I. Silverberg, Thomas Bieber, Kenji Kabashima, Yuichiro Tsunemi, Antonio Costanzo, Emma Guttman-yassky, Jonathan M. Janes, Amy M. Delozier, Margaret Gamalo, Tracy E. Cardillo, Fabio P. Nunes, Amy S. Paller, Andreas Wollenberg, Kristian Reich